Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-20-095993
Filing Date
2020-04-02
Accepted
2020-04-02 16:16:56
Documents
4
Period of Report
2020-05-12
Effectiveness Date
2020-04-02

Document Format Files

Seq Description Document Type Size
1 DEF 14A d896809ddef14a.htm DEF 14A 431866
2 GRAPHIC g896809g92k40.jpg GRAPHIC 30369
3 GRAPHIC g896809page001.jpg GRAPHIC 76205
4 GRAPHIC g896809page002.jpg GRAPHIC 58697
  Complete submission text file 0001193125-20-095993.txt   661092
Mailing Address 520 PIKE STREET SUITE 2250 SEATTLE WA 98101
Business Address 520 PIKE STREET SUITE 2250 SEATTLE WA 98101 425-686-1500
ACHIEVE LIFE SCIENCES, INC. (Filer) CIK: 0000949858 (see all company filings)

EIN.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 033-80623 | Film No.: 20769183
SIC: 2835 In Vitro & In Vivo Diagnostic Substances